Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders
Galapagos CEO eyes exit as spinout names leader. Longtime NIH leader set to retire as chief of staff. Lilly exec jumps to Zealand.
Darren Incorvaia
,
Zoey Becker
Apr 25, 2025 8:30am
AIRNA appoints Elevidys architect as CMO—Chutes & Ladders
Apr 18, 2025 8:30am
Ironwood mulls options after FDA demands further GI drug study
Apr 14, 2025 10:51am
FDA plans to end animal testing for new monoclonal antibody INDs
Apr 11, 2025 1:22pm
FDA rocked by leadership shake-ups—Chutes & Ladders
Apr 4, 2025 8:30am
Corcept's phase 3 cancer win sends stock skyrocketing 85%
Mar 31, 2025 10:25am
